69464 Federal Register / Vol. 75, No. 218 / Friday, November 12, 2010 / Notices 

registration as a bulk manufacturer of 

the basic classes of controlled 

substances listed. 

Dated: November 1, 2010. 

Joseph T. Rannazzisi, 

Deputy Assistant Administrator, Office of 

Diversion Control, Drug Enforcement 

Administration. 

[FR Doc. 2010–28536 Filed 11–10–10; 8:45 am] 

BILLING CODE 4410–09–P 

DEPARTMENT OF JUSTICE 

Drug Enforcement Administration 

Manufacturer of Controlled 

Substances; Notice of Application 

Pursuant to § 1301.33(a), Title 21 of 

the Code of Federal Regulations (CFR), 

this is notice that on July 8, 2010, 

Noramco Inc., 1440 Olympic Dr., 

Athens, Georgia 30601, made 

application by renewal to the Drug 

Enforcement Administration (DEA) as a 

bulk manufacturer of the basic classes of 

controlled substances listed in 

schedules I and II: 

Drug Schedule 

Codeine-N-Oxide (9053) .............. I 

Morphine-N-Oxide (9307) ............. I 

Amphetamine (1100) .................... II 

Methylphenidate (1724) ................ II 

Codeine (9050) ............................. II 

Dihydrocodeine (9120) ................. II 

Oxycodone (9143) ........................ II 

Hydromorphone (9150) ................ II 

Hydrocodone (9193) ..................... II 

Morphine (9300) ........................... II 

Oripavine (9330) ........................... II 

Thebaine (9333) ........................... II 

Oxymorphone (9652) ................... II 

Noroxymorphone (9668) .............. II 

Alfentanil (9737) ........................... II 

Sufentanil (9740) .......................... II 

Carfentanil (9743) ......................... II 

Tapentadol (9780) ........................ II 

Fentanyl (9801) ............................ II 

The company plans to manufacture 

the listed controlled substances in bulk 

for distribution to its customers. 

Any other such applicant, and any 

person who is presently registered with 

DEA to manufacture such substances, 

may file comments or objections to the 

issuance of the proposed registration 

pursuant to 21 CFR 1301.33(a). 

Any such written comments or 

objections should be addressed, in 

quintuplicate, to the Drug Enforcement 

Administration, Office of Diversion 

Control, Federal Register Representative 

(ODL), 8701 Morrissette Drive, 

Springfield, Virginia 22152; and must 

be filed no later than January 11, 2011. 

Dated: November 1, 2010. 

Joseph T. Rannazzisi, 

Deputy Assistant Administrator, Office of 

Diversion Control, Drug Enforcement 

Administration. 

[FR Doc. 2010–28524 Filed 11–10–10; 8:45 am] 

BILLING CODE 4410–09–P 

DEPARTMENT OF JUSTICE 

Drug Enforcement Administration 

Manufacturer of Controlled 

Substances; Notice of Application 

Pursuant to § 1301.33(a), Title 21 of 

the Code of Federal Regulations (CFR), 

this is notice that on July 16, 2009, 

Cerilliant Corporation, 811 Paloma 

Drive, Suite A, Round Rock, Texas 

78665–2402, made application by 

renewal to the Drug Enforcement 

Administration (DEA) to be registered as 

a bulk manufacturer of the basic classes 

of controlled substances listed in 

schedules I and II: 

Drug Schedule 

Cathinone (1235) ......................................................................................................................................................................................... I 

Methcathinone (1237) .................................................................................................................................................................................. I 

N-Ethylamphetamine (1475) ........................................................................................................................................................................ I 

N,N-Dimethylamphetamine (1480) .............................................................................................................................................................. I 

Aminorex (1585) .......................................................................................................................................................................................... I 

4-Methylaminorex (cis isomer) (1590) ......................................................................................................................................................... I 

Gamma-Hydroxybutyric acid (2010) ............................................................................................................................................................ I 

Methaqualone (2565) .................................................................................................................................................................................. I 

Alpha-ethyltryptamine (7249) ...................................................................................................................................................................... I 

Lysergic acid diethylamide (7315) ............................................................................................................................................................... I 

2,5-Dimethoxy-4-(n)-propylthiophenethylamine (7348) ............................................................................................................................... I 

Marihuana (7360) ........................................................................................................................................................................................ I 

Tetrahydrocannabinols (7370) ..................................................................................................................................................................... I 

Mescaline (7381) ......................................................................................................................................................................................... I 

3,4,5-Trimethoxyamphetamine (7390) ........................................................................................................................................................ I 

4-Bromo-2,5-dimethoxyamphetamine (7391) .............................................................................................................................................. I 

4-Bromo-2,5-dimethoxyphenethylamine (7392) .......................................................................................................................................... I 

4-Methyl-2,5-dimethoxyamphetamine (7395) .............................................................................................................................................. I 

2,5-Dimethoxyamphetamine (7396) ............................................................................................................................................................ I 

2,5-Dimethoxy-4-ethylamphetamine (7399) ................................................................................................................................................ I 

3,4-Methylenedioxyamphetamine (7400) .................................................................................................................................................... I 

5-Methoxy-3,4-methylenedioxyamphetamine (7401) .................................................................................................................................. I 

N-Hydroxy-3,4-methylendioxyamphetamine (7402) .................................................................................................................................... I 

3,4-Methylendioxy-N-ethylamphetamine (7404) .......................................................................................................................................... I 

3,4-Methylenedioxymethamphetamine (7405) ............................................................................................................................................ I 

4-Methoxyamphetamine (7411) ................................................................................................................................................................... I 

Alpha-methyltryptamine (7432) ................................................................................................................................................................... I 

Bufotenine (7433) ........................................................................................................................................................................................ I 

Diethyltryptamine (7434) ............................................................................................................................................................................. I 

Dimethyltryptamine (7435) .......................................................................................................................................................................... I 

Psilocybin (7437) ......................................................................................................................................................................................... I 

Psilocyn (7438) ............................................................................................................................................................................................ I 

5-Methoxy-N,N-diisopropyltyptamine (7439) ............................................................................................................................................... I 

N-Benzylpiperazine (7493) .......................................................................................................................................................................... I 

Acetyldihydrocodeine (9051) ....................................................................................................................................................................... I 

Benzylmorphine (9052) ............................................................................................................................................................................... I 

Codeine-N-oxide (9053) .............................................................................................................................................................................. I 

Dihydromorphine (9145) .............................................................................................................................................................................. I 

mstockstill on DSKH9S0YB1PROD with NOTICES

Federal Register / Vol. 75, No. 218 / Friday, November 12, 2010 / Notices 69465 

Drug Schedule 

Heroin (9200) ............................................................................................................................................................................................... I 

Hydromorphinol (9301) ................................................................................................................................................................................ I 

Methyldihydromorphine (9304) .................................................................................................................................................................... I 

Morphine-N-oxide (9307) ............................................................................................................................................................................. I 

Normorphine (9313) .................................................................................................................................................................................... I 

Pholcodine (9314) ....................................................................................................................................................................................... I 

Acetylmethadol (9601) ................................................................................................................................................................................. I 

Allylprodine (9602) ....................................................................................................................................................................................... I 

Alphacetylmethadol except levo-alphacetylmethadol (9603) ...................................................................................................................... I 

Alphameprodine (9604) ............................................................................................................................................................................... I 

Alphamethadol (9605) ................................................................................................................................................................................. I 

Betacetylmethadol (9607) ............................................................................................................................................................................ I 

Betameprodine (9608) ................................................................................................................................................................................. I 

Betamethadol (9609) ................................................................................................................................................................................... I 

Betaprodine (9611) ...................................................................................................................................................................................... I 

Hydroxypethidine (9627) ............................................................................................................................................................................. I 

Noracymethadol (9633) ............................................................................................................................................................................... I 

Norlevorphanol (9634) ................................................................................................................................................................................. I 

Normethadone (9635) ................................................................................................................................................................................. I 

Trimeperidine (9646) ................................................................................................................................................................................... I 

Phenomorphan (9647) ................................................................................................................................................................................. I 

1-Methyl-4-phenyl-4-propionoxypiperidine (9661) ....................................................................................................................................... I 

Tilidine (9750) .............................................................................................................................................................................................. I 

Para-Fluorofentanyl (9812) .......................................................................................................................................................................... I 

3-Methylfentanyl (9813) ............................................................................................................................................................................... I 

Alpha-Methylfentanyl (9814) ........................................................................................................................................................................ I 

Acetyl-alpha-methylfentanyl (9815) ............................................................................................................................................................. I 

Beta-hydroxyfentanyl (9830) ....................................................................................................................................................................... I 

Beta-hydroxy-3-methylfentanyl (9831) ........................................................................................................................................................ I 

Alpha-Methylthiofentanyl (9832) .................................................................................................................................................................. I 

3-Methylthiofentanyl (9833) ......................................................................................................................................................................... I 

Thiofentanyl (9835) ...................................................................................................................................................................................... I 

Amphetamine (1100) ................................................................................................................................................................................... II 

Methamphetamine (1105) ........................................................................................................................................................................... II 

Lisdexamfetamine (1205) ............................................................................................................................................................................ II 

Phenmetrazine (1631) ................................................................................................................................................................................. II 

Methylphenidate (1724) ............................................................................................................................................................................... II 

Amobarbital (2125) ...................................................................................................................................................................................... II 

Pentobarbital (2270) .................................................................................................................................................................................... II 

Secobarbital (2315) ..................................................................................................................................................................................... II 

Glutethimide (2550) ..................................................................................................................................................................................... II 

Nabilone (7379) ........................................................................................................................................................................................... II 

1-Phenylcyclohexylamine (7460) ................................................................................................................................................................. II 

Phencyclidine (7471) ................................................................................................................................................................................... II 

1-Piperidinocyclohexanecarbonitrile (8603) ................................................................................................................................................ II 

Alphaprodine (9010) .................................................................................................................................................................................... II 

Cocaine (9041) ............................................................................................................................................................................................ II 

Codeine (9050) ............................................................................................................................................................................................ II 

Dihydrocodeine (9120) ................................................................................................................................................................................ II 

Oxycodone (9143) ....................................................................................................................................................................................... II 

Hydromorphone (9150) ............................................................................................................................................................................... II 

Diphenoxylate (9170) .................................................................................................................................................................................. II 

Benzoylecgonine (9180) .............................................................................................................................................................................. II 

Ethylmorphine (9190) .................................................................................................................................................................................. II 

Hydrocodone (9193) .................................................................................................................................................................................... II 

Levomethorphan (9210) .............................................................................................................................................................................. II 

Levorphanol (9220) ..................................................................................................................................................................................... II 

Isomethadone (9226) .................................................................................................................................................................................. II 

Meperidine (9230) ....................................................................................................................................................................................... II 

Meperidine intermediate-A (9232) ............................................................................................................................................................... II 

Meperidine intermediate-B (9233) ............................................................................................................................................................... II 

Meperidine intermediate-C (9234) ............................................................................................................................................................... II 

Methadone (9250) ....................................................................................................................................................................................... II 

Methadone intermediate (9254) .................................................................................................................................................................. II 

Dextropropoxyphene, bulk (non-dosage forms) (9273) .............................................................................................................................. II 

Morphine (9300) .......................................................................................................................................................................................... II 

Thebaine (9333) .......................................................................................................................................................................................... II 

Levo-alphacetylmethadol (9648) ................................................................................................................................................................. II 

Oxymorphone (9652) ................................................................................................................................................................................... II 

Noroxymorphone (9668) .............................................................................................................................................................................. II 

Racemethorphan (9732) .............................................................................................................................................................................. II 

Alfentanil (9737) .......................................................................................................................................................................................... II 

Sufentanil (9740) ......................................................................................................................................................................................... II 

Tapentadol (9780) ....................................................................................................................................................................................... II 

mstockstill on DSKH9S0YB1PROD with NOTICES

69466 Federal Register / Vol. 75, No. 218 / Friday, November 12, 2010 / Notices 

Drug Schedule 

Fentanyl (9801) ........................................................................................................................................................................................... II 

The company plans to manufacture 

small quantities of the listed controlled 

substances to make reference standards 

which will be distributed to their 

customers. 

Any other such applicant, and any 

person who is presently registered with 

DEA to manufacture such substances, 

may file comments or objections to the 

issuance of the proposed registration 

pursuant to 21 CFR 1301.33(a). 

Any such written comments or 

objections should be addressed, in 

quintuplicate, to the Drug Enforcement 

Administration, Office of Diversion 

Control, Federal Register Representative 

(ODL), 8701 Morrissette Drive, 

Springfield, Virginia 22152; and must be 

filed no later than January 11, 2011. 

Dated: November 1, 2010. 

Joseph T. Rannazzisi, 

Deputy Assistant Administrator, Office of 

Diversion Control, Drug Enforcement 

Administration. 

[FR Doc. 2010–28516 Filed 11–10–10; 8:45 am] 

BILLING CODE 4410–09–P 

DEPARTMENT OF JUSTICE 

Drug Enforcement Administration 

Manufacturer of Controlled 

Substances; Notice of Registration 

By Notice dated April 26, 2010, and 

published in the Federal Register on 

April 30, 2010 (75 FR 22844), Lonza 

Riverside, 900 River Road, 

Conshohocken, Pennsylvania 19428, 

made application by renewal to the 

Drug Enforcement Administration 

(DEA) to be registered as a bulk 

manufacturer of the basic classes of 

controlled substances listed in 

schedules I and II: 

Drug Schedule 

Gamma hydroxybutyric acid 

(2010).

I 

Amphetamine (1100) .................... II 

Methylphenidate (1724) ................ II 

The company plans to manufacture 

bulk active pharmaceutical ingredients 

(API’s) for distribution to its customers. 

No comments or objections have been 

received. DEA has considered the 

factors in 21 U.S.C. 823(a) and 

determined that the registration of 

Lonza Riverside to manufacture the 

listed basic classes of controlled 

substances is consistent with the public 

interest at this time. DEA has 

investigated Lonza Riverside to ensure 

that the company’s registration is 

consistent with the public interest. The 

investigation has included inspection 

and testing of the company’s physical 

security systems, verification of the 

company’s compliance with state and 

local laws, and a review of the 

company’s background and history. 

Therefore, pursuant to 21 U.S.C. 823(a), 

and in accordance with 21 CFR 1301.33, 

the above named company is granted 

registration as a bulk manufacturer of 

the basic classes of controlled 

substances listed. 

Dated: November 1, 2010. 

Joseph T. Rannazzisi, 

Deputy Assistant Administrator, Office of 

Diversion Control, Drug Enforcement 

Administration. 

[FR Doc. 2010–28518 Filed 11–10–10; 8:45 am] 

BILLING CODE 4410–09–P 

DEPARTMENT OF JUSTICE 

Drug Enforcement Administration 

Manufacturer of Controlled 

Substances; Notice of Registration 

By Notice dated March 29, 2010, and 

published in the Federal Register on 

April 16, 2010, (75 FR 20001), Siemens 

Healthcare Diagnostics Inc., Attn: RA, 

100 GBC Drive, Mail Stop 514, Newark, 

Delaware 19702, made application by 

renewal to the Drug Enforcement 

Administration (DEA) to be registered as 

a bulk manufacturer of the basic classes 

of controlled substances listed in 

schedules I and II: 

Drug Schedule 

Tetrahydrocannabinols (7370) ..... I 

Ecgonine (9180) ........................... II 

Morphine (9300) ........................... II 

The company utilizes the listed 

controlled substances in bulk to 

manufacture in-vitro diagnostic test kits. 

The company distributes the test kits for 

sale to its customers. The process used 

in manufacturing the test kits 

irreversibly alters the controlled 

substances involved in such a manner 

that they are no longer classified as 

controlled substances as defined under 

the Controlled Substances Act. 

No comments or objections have been 

received. DEA has considered the 

factors in 21 U.S.C. 823(a) and 

determined that the registration of 

Siemens Healthcare Diagnostics Inc. to 

manufacture the listed basic classes of 

controlled substances is consistent with 

the public interest at this time. DEA has 

investigated Siemens Healthcare 

Diagnostics Inc. to ensure that the 

company’s registration is consistent 

with the public interest. The 

investigation has included inspection 

and testing of the company’s physical 

security systems, verification of the 

company’s compliance with state and 

local laws, and a review of the 

company’s background and history. 

Therefore, pursuant to 21 U.S.C. 823(a), 

and in accordance with 21 CFR 1301.33, 

the above named company is granted 

registration as a bulk manufacturer of 

the basic classes of controlled 

substances listed. 

Dated: November 1, 2010. 

Joseph T. Rannazzisi, 

Deputy Assistant Administrator, Office of 

Diversion Control, Drug Enforcement 

Administration. 

[FR Doc. 2010–28531 Filed 11–10–10; 8:45 am] 

BILLING CODE 4410–09–P 

DEPARTMENT OF JUSTICE 

Drug Enforcement Administration 

Manufacturer of Controlled 

Substances; Notice of Registration 

By Notice dated June 17, 2010, and 

published in the Federal Register on 

June 28, 2010, (75 FR 36684), Varian 

Inc., 25200 Commercentre Drive, Lake 

Forest, California 92630–8810, made 

application by renewal to the Drug 

Enforcement Administration (DEA) to 

be registered as a bulk manufacturer of 

the basic classes of controlled 

substances listed in schedule II: 

Drug Schedule 

Phencyclidine (7471) ................................................................................................................................................................................... II 

1-Piperidinocyclohexanecarbonitrile (8603) ................................................................................................................................................ II 

mstockstill on DSKH9S0YB1PROD with NOTICES